SNT 2.22% 4.4¢ syntara limited

Ann: Pharmaxis Announces Positive Combined Phase , page-6

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 163 Posts.
    re: Ann: Pharmaxis Announces Positive Combine... Europe
    ? Orphan drug designation
    ? EMA submission Oct 2009
    ? EMA response anticipated Q4 2010
    ? First sales 1H 2011
    USA
    ? Orphan drug designation
    ? Headline data June 2010
    ? NDA submission 1H 2011
    ? FDA response anticipated 1H 2012
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.4¢
Change
-0.001(2.22%)
Mkt cap ! $60.41M
Open High Low Value Volume
4.5¢ 4.5¢ 4.2¢ $113.6K 2.566M

Buyers (Bids)

No. Vol. Price($)
1 7047 4.4¢
 

Sellers (Offers)

Price($) Vol. No.
4.5¢ 691528 3
View Market Depth
Last trade - 15.46pm 03/10/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.